Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Feb-20 8:19 PM View:  | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 15,384 | $2.60 | $39,998.40 | 769% 2.0K to 17.38K | |
| 13-Nov-19 7:07 PM View: | Kezar Life Sciences, Inc. (KZR) | 13-Nov-19 | Market Purchase | 800 | $2.76 | $2,207.04 | 67% 1.2K to 2.0K | 103% |
| 21-Aug-19 7:38 PM View: | Kezar Life Sciences, Inc. (KZR) | 20-Aug-19 | Market Purchase | 200 | $4.42 | $884.00 | 20% 1.0K to 1.2K | 27% |
| 12-Aug-19 7:41 PM View: | Kezar Life Sciences, Inc. (KZR) | 09-Aug-19 | Market Purchase | 500 | $4.82 | $2,410.00 | 100% 0.5K to 1.0K | 16% |
| 26-Jul-19 5:14 PM View: | Kezar Life Sciences, Inc. (KZR) | 26-Jul-19 | Market Purchase | 56 | $5.80 | $324.80 | 13% 0.44K to 0.5K | (4%) |
| 26-Jul-19 5:14 PM View: | Kezar Life Sciences, Inc. (KZR) | 25-Jul-19 | Market Purchase | 444 | $5.65 | $2,510.38 | 100% 0 to 0.44K | (1%) |
| 28-Feb-18 7:24 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-18 | Grant | 3,000 | -- | -- | 5% 57.47K to 60.47K | |
| 07-Feb-18 2:15 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-18 | Payment of Exercise | 1,048 | $18.42 | $19,304.20 | (2%) 58.52K to 57.47K | (106%) |
| 06-Sep-17 7:59 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-17 | Payment of Exercise | 921 | $34.34 | $31,627.10 | (2%) 59.44K to 58.52K | (10%) |
| 03-Mar-17 1:27 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Mar-17 | Payment of Exercise | 18,881 | $44.77 | $845,302.00 | (24%) 78.32K to 59.44K | 15% |
| 09-Feb-17 7:21 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 07-Feb-17 | Grant | 12,656 | -- | -- | 19% 65.67K to 78.32K | |
| 05-Jan-17 2:16 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 03-Jan-17 | Payment of Exercise | 2,281 | $48.60 | $110,857.00 | (3%) 67.95K to 65.67K | 22% |
| 01-Sep-16 7:40 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-16 | Payment of Exercise | 17,980 | $44.74 | $804,425.00 | 36% 49.97K to 67.95K | (15%) |
| 29-Aug-16 6:52 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Aug-16 | Grant | 5,000 | -- | -- | 6% 80.93K to 85.93K | |
| 26-Apr-16 7:32 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 22-Apr-16 | Option Exercise | 34,102 | $9.37 | $319,373.00 | 42% 80.93K to 115.03K | |
| 26-Apr-16 7:32 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 22-Apr-16 | Market Option Sale (Planned) | 34,102 | $50.00 | $1,705,250.00 | (30%) 115.03K to 80.93K | 24% |
| 08-Apr-16 2:30 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 06-Apr-16 | Option Exercise | 20,814 | $7.53 | $156,713.00 | 26% 80.93K to 101.74K | |
| 08-Apr-16 2:30 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 06-Apr-16 | Market Option Sale (Planned) | 20,814 | $45.04 | $937,463.00 | (20%) 101.74K to 80.93K | 16% |
| 31-Mar-16 6:39 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Mar-16 | Option Exercise | 9,052 | $4.56 | $41,277.10 | 11% 80.93K to 89.98K | |
| 31-Mar-16 6:39 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Mar-16 | Market Option Sale (Planned) | 9,052 | $40.01 | $362,170.00 | (10%) 89.98K to 80.93K | 5% |
| 31-Mar-16 6:39 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 29-Mar-16 | Option Exercise | 4,824 | $4.56 | $21,997.40 | 6% 80.93K to 85.75K | |
| 31-Mar-16 6:39 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 29-Mar-16 | Market Option Sale (Planned) | 4,824 | $40.00 | $192,960.00 | (6%) 85.75K to 80.93K | 5% |
| 21-Aug-15 7:19 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Aug-15 | Grant | 75,000 | -- | -- | 1320% 5.68K to 80.68K | |
| 04-May-15 4:45 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Apr-15 | Grant | 5,680 | -- | -- | 100% 0 to 5.68K | |
| 15-Oct-09 4:55 PM View: | Cell Genesys, Inc. (CEGE) | 14-Oct-09 | Disposition | 6,456 | -- | -- | (100%) 6.46K to 0 | |
| 01-Aug-08 4:51 PM View: | Cell Genesys, Inc. (CEGE) | 31-Jul-08 | Payment of Exercise | 3,664 | $3.11 | $11,376.70 | (36%) 10.12K to 6.46K | 86% |
| 01-Aug-07 4:11 PM View: | Cell Genesys, Inc. (CEGE) | 30-Jul-07 | Grant | 10,120 | -- | -- | 100% 0 to 10.12K |